Monoclonal antibody-based design of antitumor drugs: Prerequisites and progress

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 12, 2004, Pages 10-16

  Chmutin, Ye F ^a   Ivanov, P K ^a   Baryshnikov, A Yu ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATEMA; IMYTERAN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; ALEMTUZUMAB; AMINOGLYCOSIDE; CANCER ANTIBODY; GEMTUZUMAB; RECOMBINANT DNA; RITUXIMAB; TRASTUZUMAB; TUMOR ANTIGEN;

ARTICLE; DRUG DESIGN; MEDICAL TECHNOLOGY; TUMOR; ANIMAL; CLINICAL TRIAL; COMPARATIVE STUDY; HUMAN; HYBRIDOMA; IMMUNOLOGY; MEDICAL RESEARCH; MOUSE; NEOPLASM; RUSSIAN FEDERATION;

AMINOGLYCOSIDES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; CLINICAL TRIALS; DNA, RECOMBINANT; DRUG DESIGN; HUMANS; HYBRIDOMAS; MICE; NEOPLASMS; RUSSIA;

EID: 15044358380     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Alcindor T., Witzig T. E. // Curr. Treat. Options Oncol. - 2002. - Vol. 3, N 4. - P. 275-282.
2. Alvarado Y., Tsimberidou A., Kantarjian H. et al. // Cancer Chemother. Pharmacol. - 2003. - Vol. 51, N 1. - P. 87-90.
3. Baselga J., Tripathy D., Mendelsohn J. et al. // Semin. Oncol. - 1999. - Vol. 4, Suppl. 12. - P. 78-83.
4. Cobleigh M. A., Vogel C. L., Tripathy D. et al. // J. Clin. Oncol. - 1999. - Vol. 17, N 9. - P. 2639-2648.
5. Coiffier B., Haioun C., Ketterer N. et al. // Blood. - 1998. - Vol. 92, N 6. - P. 1927-1932.
6. Czuczman M. S., Grillo-Lopez A. J., Whiteet M. et al. // J. Clin. Oncol. - 1999. - Vol. 17, N 1. - P. 268-276.
7. Duvic M., Cather J., Maize J. et al. // Am. J. Hematol. - 1998. - Vol. 58, N 1. - P. 87-90.
8. Ivanov P. K., Grinevich A. S., Chmutin E. F. et al. // Proceedings of 12-th International Congress on Anti-Cancer Treatment. - Paris, 2002. - P. 108.
9. Kaminski M. S., Leonard J. P., Zelenetz A. D. et al. // Materials of 38-th Annual Meeting of American Society of Clinical Oncology. - Orlando, 2002. - Absgtr. 17.
10. Kohler G., Milstein C. // Nature. - 1975. - Vol. 256. - P. 495-497.
11. Larrick J. W., Gavilondo J. // Immunotechnology. - 1998. - Vol. 3, N 4. - P. 303-307.
12. Maloney D. G., Grillo-Lopez A. J., White C. A. et al. // Blood. - 1997. - Vol. 90, N 6. - P. 2188-2195.
13. McLaughlin P., Grillo-Lopez A. J., Link B. K. et al. // J. Clin. Oncol. - 1998. - Vol. 16, N 8. - P. 2825-2833.
14. Osteborg A., Dyer M. J., Bunjes D. et al. // J. Clin. Oncol. - 1997. - Vol. 15. - P. 1567-1574.
15. Pawson R., Dyer M. J., Barge R. et al. // J. Clin. Oncol. - 1997. - Vol. 15. - P. 2667-2672.
16. Pegram M. D., Lipton A., Hayes D. F. et al. // J. Clin. Oncol. - 1998. - Vol. 16. - P. 2659-2671.
17. Pegram M. D., Slamon D. J. // Semin. Oncol. - 1999. - Vol. 26, N 4, Suppl. 12. - P. 89-95.
18. Piro L. D., White C. A., Grilla-Lopez A. J. et al. // Ann. Oncol. - 1999. - Vol. 10, N 6. - P. 655-661.
19. Press O. W., Eary J. F., Appelbaum F. R. et al. // Lancet. - 1995. - Vol. 346. - P. 336-340.
20. Riethmuller G., Schneider-Gadicke E., Schlimok G. et al. // Lancet. - 1994. - Vol. 343. - P. 1177-1183.
21. Sievers E. L., Larson R. A., Stadtmauer E. A. et al. // J. Clin. Oncol. - 2001. - Vol. 19, N 13. - P. 3244-3254.
22. Sorokin P. // Clin. J. Oncol. Nurs. - 2000. - Vol. 4, N 6. - P. 279-280.
23. Tsai D., Moore H., Hardy C. et al. // Bone Marrow Transplant. - 1999. - Vol. 24, N 5. - P. 521-526.
24. Uckun F. M. // Br. J. Haematol. - 1993. - Vol. 85, N 3. - P. 435-438.
25. Utsunomiya T., Yonezawa S., Sakamoto H. et al. // Clin. Cancer Res. - 1998. - Vol. 4, N 11. - P. 2605-2614.
26. Witzig T. E., Gordon L. I., Cabanillas F. et al. // J. Clin. Oncol. - 2002. - Vol. 20, N 10. - P. 2453-2463.